Gene Query: EFNA5

Dataset Description Geneva Score
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer 158.81
Expression profile of LNCaP/AR cells with or without HNF4G expression grown for long term in charcoal stripped-serum (CSS) media 80.9
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer 53.46
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer (RNA-Seq) 53.46
Targeted differentiation of regional ventral neuroprogenitors and related neuronal subtypes from human pluripotent stem cells 49.48
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (LNCaP RNA-seq) 46.04
Distinct regulation of alternative polyadenylation and gene expression by nuclear poly(A) polymerases 45.89
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation [RNA-Seq] 43.49
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation 43.49
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression 42.5
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression [RNA-seq] 42.5
Transcripotome analysis of different locations of hair follicles (bulb, bulge) in androgenetic alopecia 41.93
Low-Cell-Number, Single-Tube Amplification (STA) of RNAs Revealed miRNA Changes from Pluripotency to Endothelium 36.92
RNA sequencing of ESC/iPSC-derived purified PAX6-GFP neural progenitors form control and Phelan-Mcdermid patients 34.66
Changes in RNA expression in human oral cavity carcinoma cells as a result of LDB1 reduction 33.96
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons [RNA-seq] 33.52
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons 33.52
Paxillin regulates genomic networks in prostate cancer [C4-2] 33.29
RNA-seq analyses of human prostate cancer cells 33.28
Lineage specific differentiation is influenced by state of human pluripotency [RNA-seq] 33.23
Lineage specific differentiation is influenced by state of human pluripotency 33.23
Triple vectors expand AAV transfer capacity in the retina 33.19
Role for citron kinase in prostate cancer growth 29.7
Salmonella activation of STAT3 signaling by SarA effector promotes intracellular replication and production of IL-10 29.57
Functional Importance of eRNAs for Estrogen-dependent Gene Transcriptional Activation 28.78
BI Human Reference Epigenome Mapping Project 27.76
A prostate cancer chromatin interaction map 27.41
Resistance to BET inhibitor leads to new therapeutic vulnerabilities in castration resistant prostate cancer 24.22
Paxillin regulates genomic networks in prostate cancer [LNCaP] 23.97
DART-seq: an antibody-free method for global m6A detection 22.97
RNA-seq in LNCaP cell line overexpressing WT or mutant FOXA1 22.85
Forkhead domain mutations in FOXA1 drive prostate cancer cell progression 22.85
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected EVT cells 22.68
ARID1A regulates condensin II distribution and chromosomal partition [RNA-seq] 22.68
ARID1A regulates condensin II distribution and chromosomal partition 22.68
Effect of selective glucocorticoid receptor modulation (SGRM) on gene expression in human prostate cancer cell lines 22.25
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 22.15
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 22.15
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [mutant MEF2C] 21.96
Deep sequencing of transcript levels in pluripotent stem cells and their differentiated derivatives in all three germ layers 21.77
Differential Gene Expression between MCF10A and MCF7 cells 21.29
Genome-wide functional assessment of enhancer activities in the human genome 21.03
The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression 20.82
Expression profile of HNF1A knockdown and overexpression in 22RV1 and LNCaP cells respectively 20.79
Cancer avatars derived from genetically engineered pluripotent stem cells allow for longitudinal assessment of tumor development 20.03
RNA-seq analysis of RALD iPSCs after in vitro differentiation 19.71
MULTI-seq: Universal sample multiplexing for single-cell RNA sequencing using lipid-tagged indices 19.3
MUC1-C Drives Lineage Plasticity in Progression to Neuroendocrine Prostate Cancer 19.3
Brain organoids reproducibly generate the cellular diversity of the human cerebral cortex 19.22
ONECUT2 Drives Neuroendocrine Prostate Cancer Through Hypoxia Signaling 19.13
Transcriptomic profiling of HeLa cells infected with Salmonella Typhimurium 19.04
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing 18.71
RNA polymerase in pre-B-ALL cell lines 18.69
GCTM-5 positive and negative cells in pancreatic adenocarcinoma cell lines 18.65
Next Generation Sequencing Facilitates Quantitative Analysis of Human Pluripotent Stem Cell-Derived Endocardial-like And Primary Cardiac Endothelial Cell Transcriptomes 18.61
ZNF599 and DNMT3A coordinately control nuclear envelope organization by repression of SUN4 expression 18.41
TOP2B disturbed the quality of human oocytes with advanced maternal age 18.3
MARS Seq data from human cortical organoids 18.23
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 18.09
Identification and validation of differentially expressed transcripts by RNA-Sequencing of formalin-fixed, paraffin-embedded (FFPE) lung tissue from patients with Idiopathic Pulmonary Fibrosis 17.85
RNA-seq and ChIP-seq analysis of BMI1 or RING1B-silenced prostate cancer cells C4-2 17.65
Supraphysiological Androgens Repress Prostate Cancer Growth and Induce DNA Damage Augmented by PARP Inhibition 17.63
FUS mutant human motoneurons transcriptome analysis reveals altered pathways and impairment of microRNA function 17.61
Slit2 modifies VEGF-induced angiogenic responses in rabbit skeletal muscle by inducing capillary sprouting and decreasing vascular permeability via reduced eNOS activity 17.49
Club cells surviving influenza A virus infection induce temporary non-specific anti-viral immunity 17.37
CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer 17.17
RNA-seq of UGP2 mutant human embryonic stem cells and in vitro differentiated neural stem cells 17.07
Generation, transcriptome profiling, and functional validation of cone-enriched human retinal organoids 16.69
Gene expression profiling of LNCaP cells following shRNA-mediated knockdown of TMEFF2 and growth in presence and absence of dihydrotestosterone 16.55
Single cell analysis of HSV-1 infection reveals anti-viral and developmental programs are activated in distinct sub-populations with opposite outcomes 16.38
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_sgrna] 16.25
RNA sequencing, chromatin accesibility and ChIP seq analysis of BAP1 -/- human liver organoids 16.2
Genome-scale screens identify JNK/JUN signaling as a barrier for pluripotency exit and endoderm differentiation 16.19
Simultaneous quantification of antibody-RNA conjugates and the transcriptome from fixed cells by RAID 16.13
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations 16.01
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations [RNA-seq] 16.01
In vitro differentiation of human low threshold mechanoreceptive (LTMR) neurons from embryonic stem cells 15.94
Defining a microRNA-mRNA targetome for calcineurin inhibitor induced nephrotoxicity 15.93
Replicated transcriptome profiling of Normal and Cancerous Prostate Cells [RNA-Seq] 15.5
Human iPSC-derived cells and microengineered Organ-Chip enhance neural development. 15.41
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia 15.24
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia [RNA-seq] 15.24
Transcriptomic Profiling of Developing Human Paraxial Mesoderm from 4.5-5 Weeks of Gestation Human Embryos 15.12
Effect of FGF13 depletion on the H460 cell line 14.92
Interleukin-1β induces mitochondrial DAMP production to activate STING-dependent innate immune programs 14.67
The BCL6 RD2 domain governs commitment of activated B-cells to form germinal centers 14.64
Entrectinib Resistance in a Neuroblastoma Xenograft Model 14.52
Rapid neurogenesis through transcriptional activation in human stem cell (RNA-Seq) 14.44
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-Seq] 14.2
Targeted inhibition of STAT/TET1 axis as a potent therapeutic strategy for acute myeloid leukemia 14.13
Effect of CTCF and Rad21 knockdown on SLK cells and KSHV gene expression 14.08
Identification of metabolically distinct adipocyte progenitor cells in human adipose tissues 14.02
Transcriptome profiling of Normal and Cancerous Prostate Cells 13.96
In vitro modeling of human germ cell development using pluripotent stem cells 13.8
A global identification of PUM1 and PUM2 mRNA targets and their protein cofactors in human seminoma TCam-2 cells 13.71
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques 13.36
Maturation of human iNSCs 13.31
Sensing self and nonself circular RNAs 13.3
RNA-seq and Microarray in Transcriptome Profiling of Anterior Cruciate Ligament Tears: Implications for Prognostic Biomarkers Discovery 13.29
Single-cell transcriptomics of the human retinal pigment epithelium and choroid in health and macular degeneration 13.21
Histone H3 Lysine4 Acetylation-Methylation Dynamics Define Breast Cancer Subtypes 13.05
Histone H3 lysine 4 acetylation-methylation dynamics define breast cancer subtypes [RNA-seq] 13.05
Direct Isolation and Characterization of Human Nephron Progenitors. 13.03
Depicting early human development and germ cell origin with porcine embryos 12.81
RNA-Seq of cKIT+ sorted cells from 16-16.5 week old fetal testes and ovaries and RNA-Seq of TRA-1-60+ H1 hESCs 12.78
RNA-Sequencing of human dermal lymphatic endothelial cells (HDLEC) treated with siRNA targeting YAP/TAZ and YAP5SA 12.76
Fibroblasts in cholesteatoma activate osteoclasts. 12.64
Robust generation of honemogeneous midbrain organoids with in vivo–like cellular composition facilitates neurotoxin-based Parkinson’s disease modeling 12.55
Ribosome profiling of TGFb-treated cells indicates reduced leucine availability 12.45
Selective expression of long non-coding RNAs in a breast cancer cell progression model 12.38
Transcriptome analyses of iPSC-derived neural stem/progenitor cells and cerebral organoids from monozygotic twins discordant for schizoaffective bipolar disorder 12.33
Transcriptome analysis of Zika infected neural stem cells 12.28
Zika infected neural stem cells 12.28
Effect of Hypoxia in Severe Preeclampsia through Epigenetic Regulation 12.26
Programmable RNA N6-methyladenosine editing by CRISPR-Cas9 conjugates 12.22
Single Cell RNASeq profiling of stromal vascular fraction from Subcutaneous and visceral adipose tissue 12.13
Transcriptomic insights into human decidual and peripheral blood CD8 T cells 12.1
Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of binding sites in a cell type-specific manner 12.03
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HOM] 11.99
RNA-seq analysis of SLIRP knockdown with 1nM DHT in LNCaP cells 11.92
A compendium of promoter-centered long-range chromatin interactions in diverse human tissues and cell types 11.87
mRNAseq of Huntington's disease and control patient iPSC-derived brain microvascular endothelial cells 11.83
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 11.7
Studying iPSCs from a hibernating mammal reveals molecular mechanisms of cold resistance in neural tissues 11.69
Transcriptional study of ARN8 cells treated with novel DHODH inhibitors 11.67
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator [RNA-seq] 11.67
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator 11.67
Next generation sequencing on knockdown of AC093323.3 in lung cancer cells 11.39
RNA-seq analysis of CRISPR/Cas9 generated human BMPR2 deficient endothelial cell lines harboring mutations characteristic for hereditary pulmonary hypertension (HPAH) 11.28
Wnt5a and its downstream transcription factor Stat3 are therapeutic targets for diffuse intrinsic pontine gliomas 10.79
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [d7+d14] 10.66
Global gene expression differences between blood- and lymphatic-specific human dermal microvascular endothelial cells 10.46
Role of FGFR1 in neuronal devlopment 10.39
The effects of U1 snRNA mutation in chronic lymphocytic leukemia cell lines 10.32
RNA splicing alteration on glioblastoma and normal neural stem cells 10.3
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [MB157_RNA-seq] 10.29
Single-cell transcriptome of human epithelial cells reveals novel insights into early innate immune responses to influenza virus and viral antagonism 10.29
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 10.28
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia 10.18
Single-cell analysis of human kidney organoids 10.18
The comparison of high-throughput single-cell RNA-seq methods 10.02
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 [RNA-seq] 9.92
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 9.92
A549 cell transcriptome responses to infection with H7N9 influenza virus 9.82
Single Cell RNA-Sequencing Identifies Diverse Roles of Epithelial Cells in Idiopathic Pulmonary Fibrosis 9.68
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 9.58
A myogenic double reporter human pluripotent stem cell line allows prospective isolation of skeletal muscle progenitors 9.58
Transcriptome profiling of CXCR2+ neuroendocrine (NE) tumor cells purified from patients' fresh prostate adenocarcinoma 9.53
Regulators of cellular heterogeneity in basal-like breast cancer influence symmetric versus asymmetric division rates (shRNA targeting) 9.51
RNA-Seq with DHT induction and/or GSK treatment at 24, 48 hrs and 2 weeks 9.4
FOXA1 Chromatin Binding is Regulated by LSD1-Mediated Demethylation 9.4
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 9.36
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 9.36
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation [RNA-Seq] 9.31
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation 9.31
High-throughput RNA sequencing on circular RNA profiles of human pancreatic cancer cell lines and gemcitabine resistant pancreatic cancer cell lines. 9.25
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation (Human_RWPE1_RNA-Seq) 9.25
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation 9.25
An integrative analysis of non-coding regulatory DNA variations associated with autism 9.22
Generation of Patient-Matched Malignant and Normal Primary Cell Cultures from Clear Cell Renal Cell Carcinoma Patients 9.09
Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain [Single Cell RNAseq] 9.07
Global gene expression differences between blood- and lymphatic-specific endothelial colony forming cells 9.06
Treatment Paradigms for Retinal and Macular Diseases Using 3-D Retina Cultures Derived From Human Reporter Pluripotent Stem Cell Lines 9.01
RNA-Seq with and without RNase treatment in PCa cell lines 9.0
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 8.98
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 8.98
An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch Type Alopecia Areata, Totalis and Universalis 8.91
HNRNPL and its RNA Targets in Prostate Cancer 8.84
Regulartory effect of HNRNPL and LARP on RNA expression in LNCaP prostate cancer cells 8.84
Epigenome regulation during epidermal lineage commitment [ATAC-seq, RNA-seq] 8.78
Single-cell survey of human lymphatics unveils marked endothelial cell heterogeneity and mechanisms of homing for neutrophils 8.76
Transcriptome analysis reveals determinant stages controlling human embryonic stem cell commitment to neuronal cells 8.72
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration 8.71
RNA-seq of SOX5 overexpressing primary human neuronal progenitors 8.64
Transcriptome of EMT induced MCF10A cells by TGFb treatment or SNAIL S6A expression. 8.63
PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP. 8.62
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin (RNA-seq) 8.62
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin 8.62
Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma [RNA-Seq; normal samples] 8.46
HNF1A deficiency impairs β-cell fate, granule maturation and function 8.41
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice 8.34
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice [RNA-seq] 8.34
Expression profiling and occupancy after knockdown or over-expression of HFN1A or HNF4G in prostate cancer cells 8.31
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination (RNAseq) 8.18
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination 8.18
Time series single-cell transcriptomic analysis of AEC2 directed differentiation 8.09
STX4 Over-Expression in Human islets 7.98
Comprehensive analysis of microRNA expression in regionalized human neural progenitor cells reveals microRNA-10 as a caudalizing factor 7.87
Early response of human ovarian and fallopian tube surface epithelial cells to norepinephrine 7.82
Human germ cell formation in xenotransplants of induced pluripotent stem cells carrying X chromosome aneuploidies 7.79
CD13 and ROR2 permit isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 7.74
Isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 7.74
Kidney organoid reproducibility across multiple human iPSC lines and diminished off target cells after transplantation revealed by single cell transcriptomics 7.73
ETS family proteins bind glucocorticoid receptor: relevance for treatment of Ewing sarcoma 7.7
Gene expression profile of human iPSC-derived nephron progenitor cells 7.66
Non-coding regions are the main source of tumor-specific antigens [human] 7.52
Non-coding regions are the main source of tumor-specific antigens 7.52
hESC neural differentiation 7.5
RNA-seq analysis of gene expression patterns during hESC neural differentiation 7.5
NAD+ Analog-sensitive PARPs Reveal a Role for PARP-1 in Transcription Elongation 7.49
High-throughput sequencing of the human hepatic progenitor cell niche in PSC and HCV. 7.45
Definition of Natural Killer cell heterogeneity in humans and mice by high-throughput single-cell RNA sequencing 7.41
Single-cell transcriptomic analysis of tissue resident memory T cells in human lung cancer [ 10x genomics] 7.37
UV-Irradiation Induces a Noncoding RNA that Functionally Opposes the Protein Encoded by the Same Gene 7.34
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 7.22
Generating Patterned Kidney Organoids for Studying Development and Diseases 7.17
Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cell Lines 7.17
CENPA-Bound Genes and Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cells 7.17
Transcriptional landscape changes during human embryonic stem cell derivation 7.17
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 7.14
Integrative analysis identifies lincRNAs up- and downstream of neuroblastoma driver genes (ALK) 7.1
Effect of MDK expressing Melanoma cells conditioned media in Human LEC 7.05
SNHG12 knockdown in Human Umbilical Vein Cells under ROS conditions. 7.0
Quantitative Analysis of negative control and overexpression-TRIB1 in PC3 and DU145 Transcriptomes 6.96
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 6.96
microRNA suppresses prostate cancer stem cells and metastasis by inhibiting a cohort of pro-metastasis targets including CD44, Rho GTPases and EZH2 6.93
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 6.89
Identification of global XBP1s target gene expression in human prostate cancer cells 6.88
Modeling the MYC-driven normal-to-tumour switch in breast cancer. 6.87
Cellular recruitment by podocyte-derived pro-migratory factors in assembly of the human renal filter 6.82
scRNASeq analysis of cycling cardiomyocytes 6.79
Transcriptome data from human endocrine cells recovered from mouse grafts with pre-engraftment controls 6.74
Heterogeneous nuclear ribonucleoprotein C1/C2 links transcriptional and splicing actions of 1,25-dihydroxyvitamin D 6.7
Adaptation of the Kinome Promotes Resistance to BET Bromodomain Inhibitors in Ovarian Cancer 6.65
Gene expression analysis of C4-2 cells treated with ACLY inhibitor and Enzalutamide 6.59
Transcriptome analysis in a radiosensitive and a radioresistant cell line after ionizing radiation 6.58
Lipid degradation promotes prostate cancer cell survival 6.55
HNF1 regulates critical functions of the human epididymis epithelium. 6.54
HNF1 regulates critical functions of the human epididymis epithelium. [RNA-Seq] 6.54
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 6.54
Transcriptome profiling of Cryptosporidium parvum infected lung and intestinal organoids 6.54
PANCR, the PITX2 adjacent noncoding RNA, is specifically expressed in human left atria and regulates PITX2c expression 6.53
TT-Seq captures the human transient transcriptome 6.48
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines [RNA-seq] 6.47
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines 6.47
Effects of Polybrominated Diphenyl Ether (PBDE) Mixture on estrogen receptor positive (ER+) patient-derived tumor xenograft (PDX) model 6.47
Transcriptome variation among human embryonic stem cell lines impacts on their differentiation 6.43
Global gene expression profiles of cardiac progenitors differentiated from human pluripotent stem cells in 3D culture under simulated microgravity 6.42
A faithful in vivo model of human MLL-AF4 proB acute lymphoblastic leukemia 6.42
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 6.41
Human-specific gene ARHGAP11B promotes basal progenitor amplification and neocortex expansion 6.39
TFPa/HADHA is required for fatty acid beta-oxidation and cardiolipin re-modeling in human cardiomyocytes 6.39
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells [RNA-seq] 6.33
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells 6.33
LINE-2 transposable elements are a source of functional human microRNAs and target sites 6.27
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HET] 6.21
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons 6.21
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons [RNA-Seq] 6.21
SIRT7 Antagonizes TGF-β Signaling and Inhibits Breast Cancer Metastasis 6.19
Cellular acidosis triggers MondoA transcriptional activity by driving mitochondrial ATP production 6.18
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 6.15
Analysis of active enhancers and direct androgen receptor target genes in VCaP prostate cancer cells 6.08
Single cell transcriptome of peritoneal cells 6.05
RNA-seq of H1299 cells in which either PRKCI or SOX2 was silenced by validated lentiviral shRNA constructs 6.05
Understanding the reproducibility and robustness of the kidney organoid differentiation protocol using RNA-seq 6.0
FBXW7 modulates stress response by post-translational modification of HSF1 5.99
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 5.99
Genome-wide detection of DNase I hypersensitive sites in single cells and FFPE tissue samples 5.97
Cell-specific expression and function patterns of microRNA-150-5p in liver fibrogenesis 5.93
Dynamic epigenetic remodeling underlies microRNA-mediated transdifferentiation of human adult fibroblasts into neuronal subtypes 5.89
Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence 5.87
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 5.79
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-Seq KO] 5.75
RNA-seq analysis of A498 cell line treated with siSETD2 or si-NC 5.69
Total RNA sequencing of prospective axial stem cell cultures derived from human pluripotant stem cells 5.65
Synaptic dysfunction in human neurons with Autism associated deletions in PTCHD1-AS 5.6
Organoids derived from directly reprogrammed human hepatocytes for modeling liver cancer initiation 5.51
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_compound] 5.51
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 5.51
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 5.51
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 5.5
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 5.47
ROR-γ drives androgen-receptor expression and represents a therapeutic target in castration-resistant prostate cancer 5.42
Identification of an IL-1-induced gene expression pattern in AR+ PCa cells that mimics the molecular phenotype of AR- PCa cells 5.34
RNAseq of Breast cancer PDX samples 5.29
Identification of HOXB13 target genes responsive to BET inhibitors 5.27
Poly(ADP-ribosyl)ation dependent changes in CTCF-chromatin binding and gene expression in breast cells 5.25
Exploring ILF2 regulatory genes by next-generation sequencing 5.23
Identification of PAX7-induced transcriptional changes and PAX7 genomic binding during skeletal myogenic differentiation of H9 embryonic stem cells 5.23
Single-Cell RNA Sequencing Reveals Metallothionein Heterogeneity during hESC Differentiation to Definitive Endoderm [RNA-Seq] 5.17
Tumor suppressor SMARCB1 suppresses super-enhancers to govern hESC lineage determination 5.11
A novel Menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia [RNA-Seq II] 5.1
Multiple waves of transcriptome changes during extended hypoxic induction in human pulmonary microvascular endothelial cells 5.09
SQSTM1/p62-directed metabolic reprogramming is essential for normal neurodifferentiation 5.07
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress (Total RNA) 5.03
Molecular Mechanisms of Endothelial Hyperpermeability 4.96
RNA sequencing of Formalin-Fixed, Paraffin-Embedded Specimens for Gene Expression Quantification and Data Mining 4.94
Mitochondrial phosphoenolpyruvate carboxykinase (PCK2) regulates metabolic adaptation and glucose-independent tumor cell growth 4.86
Evaluation of RNA amplification and RNA-Seq library preparation protocols for spermatozoa RNA profiling 4.83
RNA-seq analysis of control and ZC3H18-depleted ovarian cancer cells 4.82
Transcriptomes in healthy and CHB fetal hearts 4.81
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells 4.78
Human Embryoid Body Transcriptomes Reveal Maturation Differences Influenced by Size and Formation in Custom Microarrays 4.77
Effect of estrogen (E2) treatment on the C4-12 relative to the MCF7 cells 4.74
Gene expression analysis of human haploid cells (HAP1) depleted of SMARCB1 and SMARCA4 4.71
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling 4.71
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling [RNA-seq] 4.71
Human muscle-derived CLEC14A-positive cells regenerate muscle independent of PAX7 4.66
Differentiation of Induced Pluripotent Stem Cells towards Mesenchymal Stromal Cells is Hampered by Culture in 3D Hydrogels 4.65
Differentiation of Induced Pluripotent Stem Cells towards Mesenchymal Stromal Cells is Hampered by Culture in 3D Hydrogels [RNA-Seq] 4.65
Genetic regulation of human adipose microRNA expression and its consequences for metabolic traits 4.63
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 4.59
Runx1 stabilizes the mammary epithelial cell phenotype and prevents epithelial to mesenchymal transition 4.49
AMPK signaling for naïve pluripotency 4.44
AMPK signaling for naïve pluripotency [Hs] 4.44
Mutation independent activation of the Notch pathway is associated with Lapatinib resistance in Her2+ breast cancer cell lines 4.43
RNA-seq of hiPSCs-derived NPCs from 3 pairs of dizygotic discordant twins for Congenital Zika syndrome 4.42
Heterozygous and homozygous knock-in of PIK3CA-H1047R into human iPSCs 4.42
Comparison of expression profiles of APP-depleted prostate cancer cells (LNCaP) 4.41
RNA-seq of MCF10A cells and CAF 4.41
Receptor tyrosine kinase signaling promotes post-embryonic morphogenesis and survival of glia and neural progenitor cells 4.41
Discovering human diabetes-risk gene function with genetics and physiological assays 4.4
Transcriptomic insights into human decidual and peripheral blood CD4 T cells 4.4
SOX17 Is a Critical Specifier of Human Primordial Germ Cell Fate 4.36
Human stem cell based models of neuronal migration provide insight into neurological disease pathogenesis and potential treatment 4.29
GRO-seq from HCT116, MCF7 and SJSA cell lines treated with DMSO and Nutlin 4.22
Identification of a core p53 transcriptional program with highly fractionated tumor suppressive activity 4.22
Replication defective viral products exploit a cellular pro-survival mechanism to establish persistent infections 4.21
SMAD2/3 are redirected to novel sites in MCF10A MII after prolonged TGFβ stimulation 4.13
JUNB is a critical AP1 component for SMAD2/3 binding after TGFβ stimulation [RNA-seq] 4.13
RNA-Seq analysis of HIF-2a-responsive genes in clear-cell renal cell carcinoma 4.13
Insulin induced alterations in chromatin acetylation and transcriptome in triple negative breast cancer cells 4.08
Transcriptional regulation in pluripotent stem cells by Methyl CpG binding protein 2 (MeCP2) 3.99
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer [RNA-seq] 3.95
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer 3.95
Epigenome-wide analysis of DNA methylation in lung tissue shows concordance with blood studies and identifies tobacco smoke-inducible enhancers 3.9
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 3.89
Next Generation Sequencing Facilitates Quantitative Analysis of ALDH+ E-BCSC, CD24-CD44+ M-BCSC and Bulk tumor cell Transcriptomes from MC1 and Vari068 PDX models of TNBC 3.88
SLIGRL-induced gene expression changes in NHEK cells 3.82
Interphase condensins regulate ligand-depedent enhancer activation 3.79
Interphase condensins regulate ligand-depedent enhancer activation (GRO-seq) 3.79
Cranial pericytes derived from neural crest cells reveal an inherent cell type-specific defect in Alzheimer's Disease 3.78
Verification and rectification of cell type-specific splicing of a Seckel syndrome-associated ATR mutation using iPS cell model 3.78
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [ribosome profiling] 3.76
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L 3.75
Gene expression alterations of pancreatic intraepithlial neoplasia 3.67
Reversing Abnormal Neural Development by Inhibiting OLIG2 in Down Syndrome Human iPSC Brain Organoids and Neuronal Mouse Chimeras 3.61
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells [Endoderm RNA-seq and ChIP-seq data sets] 3.55
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells 3.55
Research resource: global identification of estrogen receptor β target genes in triple negative breast cancer cells 3.49
Derivation of ventrical and atrial cardiomyocytes and maturation using biowires 3.46
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines 3.4
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines [RNA-Seq] 3.4
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 3.39
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 3.39
Identifying markers predicting successful graft outcome for clinical translation of hESC-based cell therapy for Parkinson’s disease 3.37
mRNA sequencing of the mouse and human Hep-Orgs, Chol-Orgs and primary hepatocytes 3.34
Simultaneous and systematic analysis of cellular and viral gene expression during Enterovirus 71-induced host shutoff 3.32
Genome-wide mapping of TEL-AML1 targets in acute leukemia 3.31
Neuroligin-4 Regulates Excitatory Synaptic Transmission in Human Neurons 3.3
Total RNA deep sequencing (ribosomal depleted) of human umbilical vein endothelial cells exposed to hypoxia (0.2%) for 12h and 24h or kept under normoxic conditions. 3.28
Endothelial gene expression analysis 3.28
RNA-seq in neurons derived from iPSCs in controls and patients with schizophrenia and 22q11 del 3.25
Argonaute proteins couple chromatin silencing to alternative splicing (RNA IP-Seq) 3.24
Argonaute proteins couple chromatin silencing to alternative splicing 3.24
Single-cell transcription profiling in KS1 patient iPSCs and NPCs 3.24
Contribution of SRF and Nkx2-5 to androgen-dependent gene expression in prostate cancer 3.24
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 KO] 3.16
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct 3.16
Gene expression profiles of ibrutinib-responsive and ibrutinib non-responsive cells in ERBB4 expressing cancer cell lines 3.14
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation (RNA-Seq) 3.12
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation 3.12
Peptidomimetic blockade of MYB in acute myeloid leukemia [RNA-seq] 3.07
Peptidomimetic blockade of MYB in acute myeloid leukemia 3.07
Progesterone receptor transcriptome and cistrome in decidualized human endometrial stromal cells 3.07
FOXO1 is required for binding of PR on IRF4, novel transcriptional regulator of endometrial stromal decidualization 3.07
Progesterone Receptor- and FOXO1-dependent transcriptomes decidualized human endometrial stromal cells 3.07
RNA-seq data of small cell carcinoma of the bladder (SCCB) /urothelial carcinoma (Non-SCCB) clinical samples, and bladder-PARCB cell lines 3.05
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans 3.01
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans [human scRNA-seq] 3.01
Transcriptomic analysis of the role of the integrin a6b4 in detached cells 2.96
Primate transcript and protein expression levels evolve under compensatory selection pressures 2.92
Disruption of GRIN2B impairs differentiation in human neurons 2.84
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 2.83
Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology 2.8
Single amino acid change underlies distinct roles of H2A.Z subtypes in human syndrome 2.8
Next Generation Sequencing Compares Effects of microRNA-9 perturbation in control and SZ hiPSC NPCs 2.76
Heterogeneous effects of massive hypoxia pathway activation in kidney cancer 2.71
A novel non-canonical signaling pathway mediates TGF-β1-induced glucocorticoid insensitivity in epithelial cells 2.68
Characterisation of the EZH2 regulated transcriptome in de novo transformed cells (RNA-Seq) 2.67
A cell-permeable stapled peptide inhibitor of the estrogen receptor/coactivator interaction 2.62
Small-molecule targeting of brachyury transcription factor addiction in chordoma 2.57
Characterization of EZH2-deficient human embryonic stem cells [ChIP-seq and bulk RNA-seq] 2.54
SLAM-seq for K562 endogenous mRNA decay 2.51
Profiling gene expression changes in primary ovarian tumors compared to matched normal fallopian tubes 2.5
Strand-specific Dual RNA-seq of Bronchial Epithelial cells Infected with Influenza A/H3N2 Viruses Reveals Splicing of Gene Segment 6 and Novel Host-Virus Interactions 2.48
Radiation enhances melanoma response to immunotherapeutic and synergizes with benzodiazepines to promote improved anti-tumor activity 2.48
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 2.42
RNA-Seq analysis of prostate cancer cell line LNCaP treated with vehicle, androgen, androgen and IMTPPE, androgen and JJ-(+)-450, androgen and JJ-(-)450, androgen and enzalutamide 2.38
Inhibition of TAZ contributes radiation-induced senescence and growth arrest in glioma cells 2.35
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (BGI12 RNA-Seq) 2.32
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. 2.32
Uridylation-mediated RNA quality control pathway in mammalian cytoplasm [RNA-Seq] 2.32
Transcriptomic analysis of frontal fibrosing alopecia 2.32
A cell cycle-based functional screen to identify lncRNA-based cancer biomarkers 2.32
RNA-seq of human foreskin fibroblast cells lacking RB, p130, and p107 treated with doxorubicin. 2.22
Apoptosis enhancing drugs overcome innate platinum resistance in CA125 negative tumor initiating populations of high grade serous ovarian cancer 2.18
The lung-enriched p53 mutants V157F and R158L/P regulate a novel transcriptome in lung cancer 2.17
High-throughput sequencing of PROMPT-enriched samples. 2.13
Transcriptomic profile of intestinal epithelial cells obtained from ileal endoscopic biopsies from newly-diagnosed, pediatric Crohn's disease patients and healthy controls. 2.11
Illumina HiSeq Sequencing on Breast cancer PDX samples 2.06
Total RNAseq of human putamen and caudate nucleus tissues in healthy control and Bipolar Disorder individuals 2.05
RNA-Seq profiling in PBMCs and spinal cord from ALS patients and healthy controls 2.04
Comprehensive RNA-Seq profiling in PBMCs of ALS patients and healthy controls 2.04
AML subtype is a major determinant of the association between prognostic gene expression signatures and their clinical significance. 2.02
Analysis of human ES cell differentiation establishes that the dominant isoforms of the lncRNAs RMST and FIRRE are circular 1.95
SEUSS: A scalable screening platform to assess transcriptomic and fitness effects of transcription factor overexpression 1.95
RNA-Seq Analysis in purified iPS cell-derived neuronal samples 1.93
CDK4/6 inhibitor resistance in prostate cancer 1.92
Compensatory Csf2-driven macrophage activation blunts long-term efficacy of therapeutic Csf1r inhibition in breast-to-brain metastasis 1.9
Genome-wide RNA-sequencing (RNA-seq) of benign and malignant prostate cell lines without and with androgen (R1881) stimulation. 1.83
Transcriptome of TNF-a-treated and untreated HeLa cells before and after TFIIB knockdown 1.81
mRNA differential expression analysis in a human ex vivo model of chronic wounds 1.81
Identification of transcripts altered upon LIN-41 knockdown in human embryonic stem cells 1.76
FOXO1 is an oncogenic mediator in AML1-ETO leukemia 1.73
GIST cell cycle dysregulation is required for progression to high-risk disease but not for resistance to kinase inhibitors 1.73
RNA sequencing of prostate cancer and normal tissue from African Americans and European Americans 1.62
Expression profiling of pancreatic adenocarcinoma and ductal adenocarcinoma cell lines. 1.59
The transcriptomic landscape of MAIT cell development in the thymus (C006 RNAseq data set) 1.57
Effects of Spaceflight on Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Structure and Function 1.57
Characterizing smoking-induced transcriptional heterogeneity in the human bronchial epithelium at single-cell resolution 1.54
Modulation of ESRP2 and MBNL2 in normal kidney and clear cell renal cell carcinoma cell lines for analysis of stability programs 1.44
The RNA-binding protein RBM47 suppresses metastatic breast cancer progression 1.44
Gene expression profile of CRC-derived HILEC 1.41
Metastasis in triple-negative breast cancer 1.38
Functional and genomic characterization of a xenograft model system for the study of metastasis in triple-negative breast cancer. 1.38
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies 1.38
The impact of oil spill to lung health – insights from an RNA-seq study of human airway epithelial cells 1.34
Transposon-based construction of strand-specific RNA-seq libraries 1.32
A High-Throughput Screen Identifies DYRK inhibitor ID-8 that Stimulates Human Kidney Tubular Proliferation 1.3
FGF2 regulation of gene expression in stable inducible Neurons 1.29
Modeling genome-wide transcriptional cis-regulation in n LNCaP-abl cell line after siRNA knock down of a series of gene factors [RNA-seq] 1.27
Human ES Cell-derived Hepatoblasts are an Optimal Lineage Stage for HCV Infection 1.25
The SS18-SSX fusion oncoprotein hijacks BAF complex targeting and function to drive synovial sarcoma [RNA-Seq Tumor] 1.21
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent 1.16
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent (RNA-seq) 1.16
Transcriptional profiling of JEG3 cells with HLA-G ablation via deletion of Enhancer L 1.16
The Genetic Landscape of Diamond-Blackfan Anemia 1.12
High-resolution comparative analysis of great ape genomes 1.12
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 1.12
Subtle asymmetry of gene expression in embryonic and foetal human brains 1.09
Persistence of stem cell metabolism in cancers as a failure of differentiation 1.08
Mutant p63 disrupts the key specification switch from the multipotent cell state to stratified epithelia during epithelial differentiation/in ectodermal dysplasia disorders 1.08
Transcriptome analysis of fetal Klinefelter testis tissue samples compared to controls 1.07
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 1.05
RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms, and GTPase binding in bipolar disorder 0.99
A single-cell transcriptome atlas of the human pancreas 0.95
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 0.93
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 0.93
RAID allows multiplexed quantification of intracellular (phospho-)proteins and transcriptomes from fixed single cells 0.92
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 0.9
mRNA-Seq profiling SIX2+ and Foxd1+ cells in mouse embryonic and SIX2+ and SIX2-/MEIS1+ cells human fetal kidney 0.88
Molecular analysis of renal cell carcinoma with unclassfied histology 0.85
Molecular analysis of renal cell carcinoma with unclassfied histology [gene expression] 0.85
Deep sequencing of transcript levels of human embryonic stem cell derived mesothelium (epithelial and mesenchymal forms) and mesothelium from neonatal mouse E15.5 of the heart, lung, liver and gut and ChIP-seq data of the mesenchymal form of mesothelium 0.82
Comparative analysis of WT and ZEB1 KO cells in different stages during differentiation 0.81
The transcriptome of Kawasaki Disease arteritis 0.75
Platelet Transcriptome Profiling in HIV and ABCC4 as a Biomarker of Platelet Activity 0.74
RNA-Seq in PWS iPSC-derived neurons 0.69
Bi-allelic Alteration and Dysregulation of the Hippo Pathway in Mucinous Tubular and Spindle Cell Carcinoma of the Kidney 0.68
Differential YAP expression in glioma cells induces cell competition and promotes tumorigenesis 0.67
Age-Related Gene Expression Changes in Prostate Cancer Patients [RNA-Seq] 0.65
Age-Related Gene Expression Changes in Prostate Cancer Patients 0.65
Glucose inhibits cardiac maturation through nucleotide biosynthesis 0.6
Long-term expandable SOX9+ chondrogenic ectomesenchymal cells from human pluripotent stem cells 0.59
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 0.58
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 0.58
single cell RNA-seq from GM12878 (ENCSR673UIY) 0.54
Ultracentifugation and nanoscale deterministic lateral displacement (nanoDLD) of samples for exRNA analysis 0.54
Vammin induces a highly efficient angiogenic response through VEGFR-2/NRP-1 and bypasses the regulatory function of VEGFR-1 0.42
Serotonin-induced hyperactivity in SSRI-resistant major depressive disorder patient-derived neurons 0.41
nELAVL HITS-CLIP in Alzheimer's Disease patients 0.4
A Basal Stem Cell Signature Identifies Aggressive Prostate Cancer Phenotypes 0.39
Next generation sequencing of small RNAs isolated from exosomes in human semen 0.39
The role of CFTR in islet function 0.39
DHX15 regulates CMTR1-dependent gene expression and cell proliferation 0.37
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells [RNA-Seq] 0.36
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells 0.36
Reduced CYFIP1 in human neural progenitors as 15q11.2 deletion model: donor specific dysregulation of schizophrenia/epilepsy genes 0.33
Global transcriptome analysis in the MYCN-amplified neuroblastoma cell line IMR5-75 upon inducible MYCN-knockdown 0.27
Mutant p53 controls tumor metabolism and metastasis by regulating PGC-1α 0.24
Transcriptome profiling of omental adipose tissues in human obesity by RNA-Seq 0.21
A single cell reference map for human blood and tissue T cell activation 0.2
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 0.18
Profiling premalignant lesions in lung squamous cell carcinomas identifies mechanisms involved in stepwise carcinogenesis 0.17
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures [RNA-Seq] 0.16
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures 0.16
Epigenetic activation and memory at a TGFB2 enhancer in systemic sclerosis 0.16
Chemical Enhancement of Direct Cardiac Reprogramming In Vitro and In Vivo 0.16
Differential susceptibility of human pleural and peritoneal mesothelial cells to asbestos exposure 0.15
Sodium butyrate ameliorates aSyn-induced transcription deregulation and DNA damage 0.1
Cutaneous Immunoprofile of Three Spotted Fever Group Rickettsiosis 0.05
CD73 knockdown effect in pancreatic cancer cell lines 0.05
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors 0.04
Effect of Ro 08-2750 treatment on gene expression of human leukemia cell lines MOLM13 and K562 0.03
Single cell RNA-seq resolves lineage-specific activation dynamics of human blood and tissue T cells 0.03
Macrophages redirect phagocytosis by non-professional phagocytes and influence inflammation 0.02
A stably self-renewing adult blood-derived induced neural stem cell exhibiting patternability and epigenetic rejuvenation 0.01
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex (Gro-seq) 0.0
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation